Banque Cantonale Vaudoise Has $2.23 Million Position in The Clorox Company $CLX

Banque Cantonale Vaudoise boosted its stake in shares of The Clorox Company (NYSE:CLX) by 78.9% during the 4th quarter, Holdings Channel reports. The institutional investor owned 22,072 shares of the company’s stock after buying an additional 9,733 shares during the quarter. Banque Cantonale Vaudoise’s holdings in Clorox were worth $2,225,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently bought and sold shares of CLX. Van ECK Associates Corp lifted its holdings in Clorox by 93.9% during the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after buying an additional 1,312,471 shares during the period. Invesco Ltd. lifted its holdings in Clorox by 23.1% during the 3rd quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock worth $492,656,000 after buying an additional 750,415 shares during the period. Northwestern Mutual Wealth Management Co. lifted its holdings in Clorox by 6,907.9% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 749,703 shares of the company’s stock worth $75,593,000 after buying an additional 739,005 shares during the period. Worldquant Millennium Advisors LLC acquired a new position in Clorox during the 2nd quarter worth about $71,856,000. Finally, Two Sigma Investments LP lifted its holdings in Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after buying an additional 439,797 shares during the period. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Pierre R. Breber bought 5,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was acquired at an average cost of $85.82 per share, with a total value of $429,100.00. Following the transaction, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. This represents a 38.46% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.63% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several research analysts have commented on the company. Weiss Ratings raised Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, April 13th. The Goldman Sachs Group reaffirmed a “sell” rating and set a $83.00 target price on shares of Clorox in a report on Friday, May 1st. Evercore reaffirmed an “underperform” rating and set a $110.00 target price on shares of Clorox in a report on Friday, May 1st. UBS Group dropped their price objective on Clorox from $110.00 to $96.00 and set a “neutral” rating on the stock in a research note on Friday, May 1st. Finally, JPMorgan Chase & Co. dropped their price objective on Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research note on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Reduce” and an average target price of $103.40.

Clorox Stock Up 1.0%

Shares of NYSE:CLX opened at $95.18 on Friday. The company has a market capitalization of $11.51 billion, a price-to-earnings ratio of 15.45, a P/E/G ratio of 0.49 and a beta of 0.59. The company has a debt-to-equity ratio of 27.03, a current ratio of 0.84 and a quick ratio of 0.65. The business’s 50-day moving average is $100.33 and its 200-day moving average is $106.37. The Clorox Company has a 1 year low of $84.70 and a 1 year high of $132.03.

Clorox (NYSE:CLX) last announced its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. The company had revenue of $1.67 billion for the quarter, compared to the consensus estimate of $1.67 billion. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The firm’s revenue was up .1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.45 EPS. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities research analysts predict that The Clorox Company will post 5.61 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, May 8th. Investors of record on Wednesday, April 22nd were given a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 5.2%. The ex-dividend date of this dividend was Wednesday, April 22nd. Clorox’s payout ratio is presently 80.52%.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.